Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Walnut Oral Immunotherapy for Tree Nut Allergy
NCT01834352Phase 2Withdrawn
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Nov 2013
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes, Allergy Immunotherapy
01
Overview
A Phase 2 trial of walnut protein flour in tree nut allergy, sponsored by University of North Carolina at Chapel Hill. Planned start Nov 2013; status: withdrawn.
02
Drugs
walnut protein flour
03
Conditions
tree nut allergy
Beyond the preview
Go deeper on NCT01834352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01834352.